APTINYX INC (APTX) Stock Price, Quote, News and Overview
NASDAQ:APTX - Nasdaq - US03836N1037 - Common Stock - Currency: USD
APTX Quote, Performance and Key Statistics
0.061
-0.04 (-39%)
The current stock price of APTX is 0.061 USD. In the past month the price decreased by -53.29%. In the past year, price decreased by -89.72%.
APTX Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About APTX
Company Profile
Aptinyx Inc. is a clinical stage biopharmaceutical company, which engages in discovery, development, and commercialization of transformative therapies for disorders of the brain and nervous system. The company is headquartered in Evanston, Illinois and currently employs 12 full-time employees. The company went IPO on 2018-06-21. The firm is focused on the discovery, development, and commercialization of proprietary, synthetic small molecules for the treatment of brain and nervous system disorders. The firm focuses on targeting and modulating N-methyl-D-aspartate receptors, (NMDArs), which are vital to the normal and effective function of the brain and nervous system. The firm's NYX-783 is in Phase 1 clinical development for the treatment of opioid use disorder (OUD), and in preclinical development for the treatment of alcohol use disorder. NYX-783 modulates NMDA receptors to increase glutamatergic activity in key regions and may act to enhance extinction learning and alleviate the emotional symptoms of opioid withdrawal. The firm's NMDAr modulator discovery platform builds on NMDAr biology. The platform has the potential to develop into a broad pipeline and product portfolio across an array of disorders of the brain and nervous system.
Company Info
APTINYX INC
1801 Maple Ave Ste 4300
Evanston ILLINOIS 60201 US
CEO: Norbert G. Riedel
Employees: 12
Company Website: https://www.aptinyx.com/
Phone: 18478710377.0
APTINYX INC / APTX FAQ
What is the stock price of APTINYX INC today?
The current stock price of APTX is 0.061 USD. The price decreased by -39% in the last trading session.
What is the ticker symbol for APTINYX INC stock?
The exchange symbol of APTINYX INC is APTX and it is listed on the Nasdaq exchange.
On which exchange is APTX stock listed?
APTX stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for APTINYX INC stock?
8 analysts have analysed APTX and the average price target is 0.51 USD. This implies a price increase of 736.07% is expected in the next year compared to the current price of 0.061. Check the APTINYX INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is APTINYX INC worth?
APTINYX INC (APTX) has a market capitalization of 4.13M USD. This makes APTX a Nano Cap stock.
How many employees does APTINYX INC have?
APTINYX INC (APTX) currently has 12 employees.
What are the support and resistance levels for APTINYX INC (APTX) stock?
APTINYX INC (APTX) has a resistance level at 0.11. Check the full technical report for a detailed analysis of APTX support and resistance levels.
Is APTINYX INC (APTX) expected to grow?
The Revenue of APTINYX INC (APTX) is expected to decline by -100% in the next year. Check the estimates tab for more information on the APTX EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy APTINYX INC (APTX) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of APTX, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of APTX, evaluating the profitability, health, valuation and growth aspects
- APTINYX INC (APTX) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- APTINYX INC (APTX) Sales and EPS estimates to see what analysts future expectations are.
- APTINYX INC (APTX) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- APTINYX INC (APTX) Insider and Institutional Ownership to learn about the owners and their transactions.
- APTINYX INC (APTX) Stock Chart to make your own analysis
- APTINYX INC (APTX) Latest news and press-releases to stay up to date.
Does APTINYX INC (APTX) stock pay dividends?
APTX does not pay a dividend.
When does APTINYX INC (APTX) report earnings?
APTINYX INC (APTX) will report earnings on 2023-08-02, after the market close.
What is the Price/Earnings (PE) ratio of APTINYX INC (APTX)?
APTINYX INC (APTX) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.96).
APTX Technical Analysis
APTX Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to APTX. APTX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
APTX Financial Highlights
Over the last trailing twelve months APTX reported a non-GAAP Earnings per Share(EPS) of -0.96. The EPS increased by 13.51% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.58 |
APTX Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 48% to APTX. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 50.06% and a revenue growth -100% for APTX